Global PCR and NGS-Based Molecular Diagnostics Market Growth (Status and Outlook) 2025-2031

According to this study, the global PCR and NGS-Based Molecular Diagnostics market size will reach US$ million by 2031.

United States market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key PCR and NGS-Based Molecular Diagnostics players cover Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “PCR and NGS-Based Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world PCR and NGS-Based Molecular Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected PCR and NGS-Based Molecular Diagnostics sales for 2025 through 2031. With PCR and NGS-Based Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCR and NGS-Based Molecular Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global PCR and NGS-Based Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PCR and NGS-Based Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCR and NGS-Based Molecular Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCR and NGS-Based Molecular Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCR and NGS-Based Molecular Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of PCR and NGS-Based Molecular Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Biomarker Discovery
Blood Sample Testig
Others

Segmentation by Application:
Hospitals
Academics/Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock

Please note: The report will take approximately 2 business days to prepare and deliver. Show more